| Literature DB >> 34564142 |
Girija Gajanan Phadke1, Nikheel Bhojraj Rathod2, Fatih Ozogul3, Krishnamoorthy Elavarasan4, Muthusamy Karthikeyan5, Kyung-Hoon Shin6, Se-Kwon Kim6.
Abstract
Developing peptide-based drugs are very promising to address many of the lifestyle mediated diseases which are prevalent in a major portion of the global population. As an alternative to synthetic peptide-based drugs, derived peptides from natural sources have gained a greater attention in the last two decades. Aquatic organisms including plants, fish and shellfish are known as a rich reservoir of parent protein molecules which can offer novel sequences of amino acids in peptides, having unique bio-functional properties upon hydrolyzing with proteases from different sources. However, rather than exploiting fish and shellfish stocks which are already under pressure due to overexploitation, the processing discards, regarded as secondary raw material, could be a potential choice for peptide based therapeutic development strategies. In this connection, we have attempted to review the scientific reports in this area of research that deal with some of the well-established bioactive properties, such as antihypertensive, anti-oxidative, anti-coagulative, antibacterial and anticarcinogenic properties, with reference to the type of enzymes, substrate used, degree of particular bio-functionality, mechanism, and wherever possible, the active amino acid sequences in peptides. Many of the studies have been conducted on hydrolysate (crude mixture of peptides) enriched with low molecular bioactive peptides. In vitro and in vivo experiments on the potency of bioactive peptides to modulate the human physiological functions beneficially have demonstrated that these peptides can be used in the prevention and treatment of non-communicable lifestyle mediated diseases. The information synthesized under this review could serve as a point of reference to drive further research on and development of functionally active therapeutic natural peptides. Availability of such scientific information is expected to open up new zones of investigation for adding value to underutilized secondary raw materials, which in turn paves the way for sustainability in fish processing. However, there are significant challenges ahead in exploring the fish waste as a source of bioactive peptides, as it demands more studies on mechanisms and structure-function relationship understanding as well as clearance from regulatory and statutory bodies before reaching the end user in the form of supplement or therapeutics.Entities:
Keywords: ACE inhibitory activity; antioxidants; bioactive peptides; fish proteins; fishery by-product
Mesh:
Substances:
Year: 2021 PMID: 34564142 PMCID: PMC8468292 DOI: 10.3390/md19090480
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Categories of waste/secondary raw materials of aquatic origin.
Figure 2Benefits of harnessing secondary raw materials from fish processing.
Figure 3Schematic presentation for production of protein hydrolysates from secondary raw materials.
Fish and secondary raw material used for deriving bioactive peptides.
| Fish | Secondary Raw Material | Reference |
|---|---|---|
| Sea bream | Fish Scales | [ |
| Alaska pollack ( | Frame | [ |
| Hoki ( | Frame | [ |
|
| Visceral organs | [ |
| Sturgeon | Visceral organs | [ |
| Tuna | Liver by-products | [ |
| Alaska pollock | Frames/backbones | [ |
| Skate | Skin | [ |
| Cod ( | Skin | [ |
|
| Roe | [ |
| Bluefin tuna | Head | [ |
| Salmon | Pectoral fin | [ |
| Seabass | Skin | [ |
| Leatherjacket | Head waste | [ |
| Japanese threadfin bream | Frame waste | [ |
| Rainbow trout | By-products | [ |
| Squid | By-products | [ |
|
| By-catch | [ |
| Salmon | By-products | [ |
| Monkfish | By-products like head and viscera | [ |
| Turbot | By-products | [ |
| Fish | Solid and liquid waste generated from processing operations | [ |
Figure 4Bioactive and functional properties of peptides obtained from secondary raw materials from the fish processing industry.
Antihypertensive characteristics of fish waste protein hydrolysates.
| Substrate | Enzymes | ACE Inhibitory Activity (%) or (IC50 Value) | Reference |
|---|---|---|---|
| Yellowfin sole frame | Chymotrypsin | Ultrafiltration fractionation- | [ |
| Protease-K | 47.4% activity | [ | |
| Alcalase | 43.0% activity | ||
| Sardine visceral enzyme | 63.2% activity | ||
| Chymotrypsin | 55.8% activity | ||
| Protease ES1 | 13.2% activity | ||
| Tilapia | Cryotin | 62–71% activity | [ |
| Flavourzyme | 66–73% activity | ||
| Jelly fish | Papain | IC50: 6.56 µM | [ |
| Freshwater clam byproducts | Pepsin | IC50: 0.23 mg/mL | [ |
| Giant Jelly fish | Alcalase | 39.61% activity | [ |
| Flavourzyme | 36.36% activity | ||
| Neutrase | 62.29% activity | ||
| Papain | 76.73% activity | ||
| Protamex | 70.01% activity | ||
| Trypsin | 68.01% activity | ||
| Rohu roe | Pepsin | 47% activity | [ |
| Trypsin | 36% activity | ||
| Pink perch fish frame waste | Papain | 69% activity | [ |
| Salmon skin | Alcalse, papain | IC50: 60 µM | [ |
| Sea bream scale | Protease | IC50: 7.5 µM | [ |
| Skate ( | Alcalase, α-chymotrypsin, neutrase, pepsin, papain and trypsin | IC50: 95 µM and 148 µM | [ |
| Tuna ( | Alcalase, neutrase, pepsin, papain, α-chymotrypsin and trypsin | IC50: 11.28 µM | [ |
| Tuna heads | Alcalase | 0.27 mg/mL | [ |
| Sardine viscera | Alcalase | 1.16 mg/mL | [ |
| Nile tilapia skin | Alcalase | 1.12 mg/mL | [ |
| Hound fish ( | Alkaline protease | 75 µg/mL | [ |
| Alaska Pollock skin gelatin extracts | Alcalase, pronase E, and collagenase | Gly-Pro-Leu and Gly-Pro-Met Peptides | [ |
Antioxidant properties of fish waste protein hydrolysates.
| Substrate | Enzymes | Bioactive Properties Studied and Peptide Sequence | Reference |
|---|---|---|---|
| Striped catfish frame meat | Papain | DPPH radical scavenging activity (90%), ferric reducing antioxidant power | [ |
| Goby muscle proteins | Alcalase | DPPH radical scavenging activity and reducing power | [ |
| Pepsin | DPPH radical scavenging activity (36–46%) | [ | |
| Salmon protein hydrolysate | Pepsin | DPPH radical scavenging activity (55%) | [ |
| Pink perch frame waste hydrolysate | Papain | DPPH free radical scavenging activity (up to 90%), ferric reducing antioxidant power | [ |
| Salmon ( | Alcalase | DPPH free radical scavenging ability, ABTS activity, ferric reducing antioxidant power (FRAP), metal chelating activity and oxygen radical antioxidant capacity (ORAC) | [ |
| Alcalase | DPPH radical scavenging activity, hydroxyl radical scavenging activity and superoxide radical anion scavenging activity | [ | |
| Black pomfret visceral protein hydrolysate | Pepsin | DPPH radical scavenging activity, FRAP and metal chelating activity (Ala-Met-Thr-Gly-Leu-Glu-Ala) | [ |
| Alaska pollack frame protein hydrolysate | Mackerel intestine crude enzyme | Higher antioxidant Activity in terms of ferric thiocyanate for peptide fraction < 1 kDa | [ |
| Tuna backbone protein hydrolysate | Alcalase, a-chymotrypsin, neutrase, papain, | Higher lipid peroxidation inhibition and DPPH free radical scavenging activity for peptide—VKAGFAWTANQQLS (1519 Da) | [ |
| Cod ( | Alcalase, neutrase, papain, trypsin, pepsin, and α-chymotrypsin | Electron spin resonance technique & | [ |
| Bluefin leatherjacket ( | Papain | DPPH radical scavenging activity, hydroxyl radicals and ABTS radicals and | [ |
| Bluefin leatherjacket ( | Trypsin, flavourzyme, neutrase, papain, alcalase, and pepsin, | DPPH, hydroxyl radicals and oxygen scavenging assays | [ |
| Salmon by-product | Alcalase, Flavourzyme, Neutrase, pepsin, Protamex, and trypsin | DPPH and ABTS | [ |
| Horse mackerel ( | DPPH and hydroxyl radicals | [ | |
| Giant catfish (Pangasianodon gigas) skin | Visceral alkaline-proteases from Giant catfish, commercial trypsin, Izyme AL® | ABTS radical-scavenging, Ferric reducing antioxidant power (FRAP) and metal (ferrous) chelating ability | [ |
| Aisan seabass ( | Protease from hepatopancreas of Pacific white shrimp, Alcalase | DPPH and ABTS radical-scavenging activity, Ferric reducing antioxidant power, metal (ferrous) chelating activity, inhibition of lipid peroxidation | [ |
| Croaker (Otolithes ruber) skin | Pepsin, trypsin, α-chymotrypsin | Gly-Asn-Arg-Gly-Phe-Ala-Cys-Arg-His-Ala and | [ |
| Jumbo squid skin gelatin | Enzymatic hydrolysis | Good antioxidant activity for isolated peptide Phe-Asp-Ser-Gly-Pro Ala-Gly-Val-Leu | [ |
Anticarcinogenic activity of peptides derived from secondary raw materials from fish processing.
| By-Product Source for Peptide | Peptide Sequence/Molecular Weight | Anticancer Effect | Researchers |
|---|---|---|---|
| Sepia Ink oligopeptides due to presence of lysine and proline in sequence | N Gln-Pro-Lys with a molecular mass | Inhibition of proliferation of human | [ |
| Tuna dark muscle peptides | Leu-Pro-His-Val-Leu-Thr-Pro-Glu-Ala-Gly-Ala-Thr | Anticarcinogenic activity against breast cancer cell line | [ |
| Snow crab by-product peptides | Two anionic peptides with MW of 537 and 216 Da and three cationic peptides with MW of 228, 241 and 291 Da | anticancer activity on colon, breast, prostate | [ |
| Shrimp shell peptide | Peptides with fractionation size < 10 and 10–30 kDa | Anticancer activity on colon and liver cancer cell lines | [ |
| Flathead by-product peptides | <3 kDa | Anticancer activity against HT-29 colon cancer cells up to 91.04% | [ |
| - | Anti-proliferative activity on human colon and liver cancer cell lines | [ | |
| Flying fish frame peptides | - | Anti-proliferative activity against | [ |
| Grouper roe peptides | - | Reduced cell viability of oral cancer cells | [ |
| Rohu roe peptides | - | Anti-proliferative | [ |
| Threadfin bream | - | Anti-proliferative activity against | [ |
| Cuttlefish mantle protein hydrolysates | - | MDA-231 and T47D cancer cell lines with growth inhibition of 78.2 and 66.2% | [ |
| Gilthead seabream byproduct peptides | - | Antiproliferative activity on human colon and breast cancer cell lines | [ |